Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Return on Invested Capital: 2011-2016

Historic Return on Invested Capital for EyePoint Pharmaceuticals (EYPT) over the last 4 years, with Jun 2016 value amounting to -0.91%.

  • EyePoint Pharmaceuticals' Return on Invested Capital fell 116.00% to -0.91% in Q2 2016 from the same period last year, while for Jun 2016 it was -0.91%, marking a year-over-year decrease of 116.00%. This contributed to the annual value of -0.98% for FY2016, which is 131.00% down from last year.
  • Per EyePoint Pharmaceuticals' latest filing, its Return on Invested Capital stood at -0.91% for Q2 2016, which was up 8.17% from -0.99% recorded in Q1 2016.
  • In the past 5 years, EyePoint Pharmaceuticals' Return on Invested Capital ranged from a high of 0.43% in Q3 2014 and a low of -1.72% during Q2 2012.
  • In the last 3 years, EyePoint Pharmaceuticals' Return on Invested Capital had a median value of -0.83% in 2014 and averaged -0.45%.
  • In the last 5 years, EyePoint Pharmaceuticals' Return on Invested Capital spiked by 162bps in 2014 and then plummeted by 152bps in 2015.
  • Over the past 5 years, EyePoint Pharmaceuticals' Return on Invested Capital (Quarterly) stood at -0.68% in 2012, then crashed by 36bps to -1.04% in 2013, then spiked by 134bps to 0.30% in 2014, then slumped by 152bps to -1.22% in 2015, then plummeted by 116bps to -0.91% in 2016.
  • Its last three reported values are -0.91% in Q2 2016, -0.99% for Q1 2016, and -1.22% during Q4 2015.